Abstract | BACKGROUND: We here report on the first observation of a C3 mutation that is related to atypical hemolytic and uremic syndrome (aHUS), which occurred in a pancreatic islet transplant patient. Immunosuppressive treatments, such as calcineurin inhibitors, have been linked to undesirable effects like nephrotoxicity. CASE PRESENTATION: CONCLUSIONS: Pancreatic islet transplantation could have triggered this aHUS episode, but this link needs to be clarified. Although prophylactic eculizumab maintains kidney allograft function, its efficacy still needs to be studied in larger populations.
|
Authors | Thibault Bahougne, Jérome Olagne, Marion Munch, Laura Braun-Parvez, Marie-Pierrette Chenard, Véronique Frémeaux-Bacchi, Sophie Caillard, Philippe Baltzinger, Michel Greget, Laurence Kessler, Bruno Moulin |
Journal | BMC nephrology
(BMC Nephrol)
Vol. 21
Issue 1
Pg. 405
(09 19 2020)
ISSN: 1471-2369 [Electronic] England |
PMID | 32950058
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Acute Kidney Injury
(etiology)
- Adult
- Atypical Hemolytic Uremic Syndrome
(genetics)
- Complement C3
(genetics)
- Diabetes Mellitus, Type 1
(surgery)
- Humans
- Islets of Langerhans
(pathology)
- Islets of Langerhans Transplantation
(adverse effects)
- Kidney Failure, Chronic
(etiology, surgery)
- Kidney Transplantation
- Male
- Mutation, Missense
|